Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 Dec 2020
Historique:
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 9 12 2020
Statut: epublish

Résumé

A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20304-y.

Identifiants

DOI: 10.1038/s41467-020-20304-y PMID: 33288767 PMC: PMC7720436
pubmed: 33288767
doi: 10.1038/s41467-020-20304-y
pii: 10.1038/s41467-020-20304-y
pmc: PMC7720436
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

6360

Commentaires et corrections

Type : ErratumFor

Auteurs

Deli Huang (D)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
ORCID: 0000-0002-6989-639X

Jenny Tuyet Tran (JT)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

Alex Olson (A)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

Thomas Vollbrecht (T)

Department of Medicine, The University of California San Diego, La Jolla, CA, USA.
ORCID: 0000-0003-1151-8844

Mary Tenuta (M)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
ORCID: 0000-0002-0708-3932

Mariia V Guryleva (MV)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Faculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow, Russia.

Roberta P Fuller (RP)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.

Torben Schiffner (T)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.

Justin R Abadejos (JR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
ORCID: 0000-0001-8271-627X

Lauren Couvrette (L)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Faculty of Science, University of Ottawa, Ottawa, Canada.

Tanya R Blane (TR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

Karen Saye (K)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.

Wenjuan Li (W)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.

Elise Landais (E)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.

Alicia Gonzalez-Martin (A)

Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain.

William Schief (W)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.
ORCID: 0000-0002-1120-0150

Ben Murrell (B)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. benjamin.murrell@ki.se.
ORCID: 0000-0002-0393-4445

Dennis R Burton (DR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA. burton@scripps.edu.
ORCID: 0000-0001-6711-9864

David Nemazee (D)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. nemazee@scripps.edu.
ORCID: 0000-0002-4769-6311

James E Voss (JE)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu.
ORCID: 0000-0002-4777-1596

Classifications MeSH